Page 19 - 中国全科医学2022-29

·3600· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn

e34c58e554e82b03b39b7b79045ab.html. interventional study［J］. Neuropsychiatr Dis Treat，2015，11：
［25］杨维立 . 建好社会心理服务中心打造阳光心灵花园［J］. 社区， 1483-1492. DOI：10.2147/NDT.S81760.
2021，21（5）：10. ［37］PARELLADA E，BIOQUE M，SERRANO M，et al. An open-
［26］北京市人民政府 . 北京市人民政府关于印发《“十四五” treatment six-week study of the clinical effectiveness of Paliperidone
时 期 健 康 北 京 建 设 规 划》 的 通 知［EB/OL］. （2021-12- Palmitate in schizophrenia：data from acute units in Spain （SHADOW
29）［2022-01-20］. http://www.beijing.gov.cn/zhengce/zfwj/ study）［J］. Int J Psychiatry Clin Pract，2018，22（3）：191-
zfwj2016/szfwj/202112/t20211229_2575955.html. 199. DOI：10.1080/13651501.2017.1404112.
［27］广东省人民政府办公厅 . 广东省人民政府办公厅关于印发广东 ［38］SCHREINER A，AADAMSOO K，ALTAMURA A C，et al.
省进一步加强精神卫生服务体系建设实施方案的通知［J］. 广 Paliperidone palmitate versus oral antipsychotics in recently
东省人民政府公报，2020，71（24）：11-17. diagnosed schizophrenia［J］. Schizophr Res，2015，169（1/2/3）：
［28］TANG C T，CHUA E C，CHEW Q H，et al. Patterns of long 393-399. DOI：10.1016/j.schres.2015.08.015.
acting injectable antipsychotic use and associated clinical factors in ［39］OHNISHI T，KOBAYASHI H，YAMAOKA T，et al. The effects
schizophrenia among 15 Asian countries and region［J］. Asia Pac of paliperidone palmitate 1 month on the employment status and
Psychiatry，2020，12（4）：e12393. DOI：10.1111/appy.12393. social functioning of patients with schizophrenia［J］. Innov Clin
［29］ZHU J L，CHEN Y，LU W，et al. Attitudes and willingness to Neurosci，2020，17（1/2/3）：36-44.
accept long-acting injections for patients with schizophrenia in ［40］LIN D E，THOMPSON-LEDUC P，GHELERTER I，et al.
Beijing：a cross-sectional investigation based on samples from the Real-world evidence of the clinical and economic impact of long-
communities［J］. Front Public Health，2021，9：770276. DOI： acting injectable versus oral antipsychotics among patients with
10.3389/fpubh.2021.770276. schizophrenia in the United States：a systematic review and meta-
［30］ABDEL-BAKI A，MEDRANO S，MARANDA C，et al. Impact analysis［J］. CNS Drugs，2021，35（5）：469-481. DOI：
of early use of long-acting injectable antipsychotics on psychotic 10.1007/s40263-021-00815-y.
relapses and hospitalizations in first-episode psychosis［J］. ［41］CORRELL C U，CITROME L，HADDAD P M，et al. The use of
Int Clin Psychopharmacol，2020，35（4）：221-228. DOI： long-acting injectable antipsychotics in schizophrenia：evaluating
10.1097/YIC.0000000000000310. the evidence［J］. J Clin Psychiatry，2016，77（suppl 3）：1-24.
［31］SEGARRA R，RECIO-BARBERO M，SÁENZ-HERRERO DOI：10.4088/JCP.15032su1.
M，et al. Oral and palmitate paliperidone long-acting injectable ［42］TAYLOR D，PATON C，KAPUR S. The Maudsley Prescribing
formulations' use in schizophrenia spectrum disorders：a Guidelines in Psychiatry［M］. 11th ed. New Jersey：Wiley-
retrospective cohort study from the first episode psychosis intervention Blackwell，2016.
program （CRUPEP）［J］. Int J Neuropsychopharmacol，2021， ［43］GARDNER D M，MURPHY A L，O'DONNELL H，et al.
24（9）：694-702. DOI：10.1093/ijnp/pyab021. International consensus study of antipsychotic dosing［J］. Am J
［32］HUANG M L，YU L，PAN F，et al. A randomized，13-week Psychiatry，2010，167（6）：686-693. DOI：10.1176/appi.
study assessing the efficacy and metabolic effects of paliperidone ajp.2009.09060802.
palmitate injection and olanzapine in first-episode schizophrenia ［44］LEUCHT S，SAMARA M，HERES S，et al. Dose equivalents for
patients［J］. Prog Neuropsychopharmacol Biol Psychiatry， second-generation antipsychotic drugs：the classical mean dose
2018，81：122-130. DOI：10.1016/j.pnpbp.2017.10.021. method［J］. Schizophr Bull，2015，41（6）：1397-1402.
［33］SUBOTNIK K L，CASAUS L R，VENTURA J，et al. Long- DOI：10.1093/schbul/sbv037.
acting injectable risperidone for relapse prevention and control of ［45］SCHREINER A，BERGMANS P，CHERUBIN P，et al.
breakthrough symptoms after a recent first episode of schizophrenia. Paliperidone palmitate in non-acute patients with schizophrenia
A randomized clinical trial［J］. JAMA Psychiatry，2015，72（8）： previously unsuccessfully treated with risperidone long-acting
822-829. DOI：10.1001/jamapsychiatry.2015.0270. therapy or frequently used conventional depot antipsychotics［J］.
［34］MUNDAY J，GREENE M，CHANG E，et al. Early initiation of J Psychopharmacol，2015，29（8）：910-922. DOI：
long-acting injectable antipsychotic treatment is associated with 10.1177/0269881115586284.
lower hospitalization rates and healthcare costs in patients with ［46］MAURI M C，FRANCO G，MINUTILLO A，et al. The switch
schizophrenia：real-world evidence from US claims data［J］. from paliperidone long-acting injectable 1- to 3-monthly：
Curr Med Res Opin，2019，35（7）：1231-1239. DOI： clinical pharmacokinetic evaluation in patients with schizophrenia
10.1080/03007995.2019.1571295. （preliminary data）［J］. J Clin Psychopharmacol，2022，42（1）：
［35］KIM S，KIM S，KOH M，et al. Effects of long-acting injectable 23-30. DOI：10.1097/JCP.0000000000001484.
paliperidone palmitate on clinical and functional outcomes in ［47］GARCIA-PORTILLA M P，BENITO RUIZ A，GÓMEZ ROBINA F，
patients with schizophrenia based on illness duration［J］. et al. Impact on functionality of the paliperidone palmitate
J Clin Psychiatry，2021，82（1）：20m13446. DOI： three-month formulation in patients with a recent diagnosis of
10.4088/JCP.20m13446. schizophrenia：a real-world observational prospective study［J］.
［36］SI T M，ZHANG K R，TANG J S，et al. Efficacy and safety Expert Opin Pharmacother，2022，23（5）：629-638. DOI：
of flexibly dosed paliperidone palmitate in Chinese patients with 10.1080/14656566.2021.2023496.
acute schizophrenia：an open-label，single-arm，prospective， ［48］PUNGOR K，SANCHEZ P，PAPPA S，et al. The Patient，